Lakshmi Gullapalli

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Artificial Intelligence

Psychometric Properties

Drug Administration

Health Promotion

Top Venues

Journal of comparative effectiveness research

ClinicoEconomics and outcomes research : CEOR

Clinical epidemiology

This page only lists publications with an associated author ORCID identifier.

Publications

Chakrapani Balijepalli, Lakshmi Gullapalli, Juhi Joshy, Nigel S B Rawson
The impact of willingness-to-pay threshold on price reduction recommendations for oncology drugs: a review of assessments conducted by the Canadian Agency for Drugs and Technologies in Health. Journal of comparative effectiveness research 13 (5) (2024)
Chakrapani Balijepalli, Lakshmi Gullapalli, Juhi Joshy, Nigel S B Rawson
The impact of willingness-to-pay threshold on price reduction recommendations for oncology drugs: a review of assessments conducted by the Canadian Agency for Drugs and Technologies in Health. Journal of comparative effectiveness research 13 (5) (2024)
Chakrapani Balijepalli, Lakshmi Gullapalli, Juhi Joshy, Nigel S B Rawson
The impact of willingness-to-pay threshold on price reduction recommendations for oncology drugs: a review of assessments conducted by the Canadian Agency for Drugs and Technologies in Health. Journal of comparative effectiveness research 13 (5) (2024)
Chakrapani Balijepalli, Lakshmi Gullapalli, Juhi Joshy, Nigel S B Rawson
The impact of willingness-to-pay threshold on price reduction recommendations for oncology drugs: a review of assessments conducted by the Canadian Agency for Drugs and Technologies in Health. Journal of comparative effectiveness research 13 (5) (2024)
Chakrapani Balijepalli, Lakshmi Gullapalli, Juhi Joshy, Nigel S B Rawson
The impact of willingness-to-pay threshold on price reduction recommendations for oncology drugs: a review of assessments conducted by the Canadian Agency for Drugs and Technologies in Health. Journal of comparative effectiveness research (2024)
Chakrapani Balijepalli, Lakshmi Gullapalli, Juhi Joshy, Nigel S B Rawson
The impact of willingness-to-pay threshold on price reduction recommendations for oncology drugs: a review of assessments conducted by the Canadian Agency for Drugs and Technologies in Health. Journal of comparative effectiveness research 13 (5) (2024)
Chakrapani Balijepalli, Lakshmi Gullapalli, Eric Druyts, Kevin Yan, Kamal Desai, Stephane Barakat, Jason Locklin
Can Standard Health Technology Assessment Approaches Help Guide the Price of Orphan Drugs in Canada? A Review of Submissions to the Canadian Agency for Drugs and Technologies in Health Common Drug Review. ClinicoEconomics and outcomes research : CEOR 12 (2020)
Kevin Yan, Kamal Desai, Lakshmi Gullapalli, Eric Druyts, Chakrapani Balijepalli
Epidemiology of Atypical Hemolytic Uremic Syndrome: A Systematic Literature Review. Clinical epidemiology 12 (2020)